Skip to main content
. 2015 Aug 23;7(10):762–769. doi: 10.14740/jocmr2278w

Figure 1.

Figure 1

Median percent changes in bone metabolism after 12 weeks of bazedoxifene treatment. Median values (first quartile, third quartile) are -18.6% (-30.9%, 12.9%) for u-NTX, -10.2% (-44.1%, 20.7%) for u-CTX, -20.6% (-27.8%, -5.8%) for TRACP, -10.1% (-17.7%, 8.6%) for OC, and -16.3% (-23.4%, -2.2%) for ucOC. u-NTX: urinary type I collagen cross-linked N-telopeptide; u-CTX: urinary type I collagen cross-linked C-telopeptide; TRACP: tartrate-resistant acid phosphatase 5b; OC: osteocalcin; ucOC: undercarboxylated osteocalcin.